Today we speak with Corey Bridges, CEO and co-founder of LifeMap Solutions, one of the companies that is trialing Apple’s newly announced ResearchKit platform.

Before venturing into mHealth waters, Corey was the Vice President of Marketing for James Cameron’s CAMERON | PACE Group (CPG), where he developed and implemented international expansion plans responsible for bringing the cinematic technology company to Europe and China. Before that, Corey was a CMO and Executive Producer for Multiverse, where he oversaw marketing, sales, and business development. Throughout his career, Core has focused on bringing positively disruptive companies to market. His additional professional highlights include launching Netflix and product-managing Internet pioneer Netscape’s flagship web browser.

Corey is obviously a guy worth talking to. Here’s what he had to say…

How would you pitch your company? What’s your elevator pitch?

LifeMap Solutions is developing innovative digital therapeutics in partnership with the Icahn Institute for Genomics and Multiscale Biology, which is located within the Icahn School of Medicine at Mount Sinai. These solutions integrate health and wellness information with care team guidance into a secure mHealth platform that empowers the patient to make better choices to achieve optimal health outcomes.

What sets you apart from competitors?

Our big differentiator is our relationship with Mt. Sinai and the Icahn Institute for Genomics and Multiscale Biology, led by Dr. Eric Schadt. Schadt is known for his work in the generation and integration of large-scale sequence variation, molecular profiling, and clinical data in disease populations. This partnership supports our product by providing an enormous analytical capability, helping us deliver data-driven results to researchers.

What’s your business model?

Our first app, Asthma Health, built in partnership with Mount Sinai, is available for users to download for free via the Apple App Store. That’s all I can share currently — we will continue to develop our business model as we grow and create new solutions in the future.

Can you share some numbers? How many users do you have?

Our first app, Asthma Health, just launched on March 9th. We look forward to seeing how many users download the app and sign-up for the mHealth study over the next few weeks.

Where do you see the company going from here?

We see that mobile technology has the potential to massively improve health outcomes for all kinds of patients and conditions, but current mHealth solutions are only just starting to bring big-data analysis to bear. It’s one thing for an app to keep track of how far you’ve run or how many calories you’ve burned, but wholly another for a new platform to combine various health data sources to analyze a holistic view of health for patients self-managing chronic conditions. Our goal is to combine patient education, engagement, and support that results in positive patient health behavior changes. Going forward, we will release separate apps that function as an intelligent health and wellness coach that leverages cutting-edge medical and behavioral research.

Where do you see the mHealth industry going?

We’re at an amazing point in history. Over the next few years, consumers will come to own and manage their health in ways that were simply not possible in the previous two thousand years of medicine. Up until now, doctors’ most widespread method of learning about patients is to ask, “So, how have you been?” But in the very near future, you, as a patient, will be able to just beam your latest biometric data to your doctor when you’re in her office. And when you’re out in the world, you’ll have an app that can be set according to your own doctor’s guidelines, for when you should proactively contact that doctor. And finally, there’s new technology that tracks a patient’s adherence to a treatment regimen. These three scenarios are direct results of the “quantified self”, telemedicine, and mHealth movements.

How long are we from seeing modern mHealth technologies going mainstream?

I think that people will look back on 2014 as the inflection point, when mHealth technology was unleashed, with the various platform technologies released by Apple, Google, Samsung, and Microsoft. Those platform technologies, like Apple’s Health app, enable an mHealth ecosystem to flourish. So now mHealth is enabled to go mainstream, and it’s just a matter of which killer apps, no bolstered by serious platform support, can gain traction with users. I think we’ll see some major winners this year, and we’ll definitely see mainstream, widespread mHealth usage in 2016.